Form 4: Eli Samaha Increases Stake in Theravance Biopharma, Inc.

Eli Samaha, managing partner of Madison Avenue Partners, LP, reports acquiring additional shares of Theravance Biopharma, Inc. through funds managed by the firm.

Summary

• On May 1, 2024, Eli Samaha reported the acquisition of Theravance Biopharma, Inc. (TBPH) shares through funds managed by Madison Avenue Partners, LP.
• Two transactions were reported: the purchase of 999,800 shares at $8.75 per share and 499,324 shares at $8.75 per share.
• Following these transactions, the total number of shares beneficially owned indirectly by Eli Samaha through Madison Avenue Partners, LP is 8,511,350.
• Eli Samaha disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a report of stock acquisition, which doesn't inherently indicate positive or negative sentiment. The increased stake could be seen as a positive signal, but it's also a routine disclosure.

Positives

• Increased investment by a managing partner could signal confidence in the company's future prospects.

Management Comments

• Eli Samaha disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The increased stake by a significant investor could positively influence shareholder confidence.

Key Dates